56 related articles for article (PubMed ID: 3967844)
1. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
[No Abstract] [Full Text] [Related]
2. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
Kan Y; Chi Z
Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
[No Abstract] [Full Text] [Related]
4. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
[TBL] [Abstract][Full Text] [Related]
5. [Glucagon test: criterion for insulin therapy in type II diabetes mellitus].
Peig M; Coves MJ; Casamitjana R; Soriano G; Guillén M; Figuerola D
Med Clin (Barc); 1985 Nov; 85(14):568-70. PubMed ID: 3908848
[No Abstract] [Full Text] [Related]
6. Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics.
Laakso M; Sarlund H; Pyörälä K
Diabetes Res; 1987 Feb; 4(2):95-9. PubMed ID: 3581663
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
[TBL] [Abstract][Full Text] [Related]
8. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
9. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
[TBL] [Abstract][Full Text] [Related]
10. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
[TBL] [Abstract][Full Text] [Related]
11. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
[No Abstract] [Full Text] [Related]
12. The role of C-peptide in the classification of diabetes mellitus.
Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-stimulated serum C-peptide levels in the early period following pancreas transplantation.
Nyberg G; von Schenck H; Nordén G; Hedman L; Frisk B
Transplant Proc; 1990 Apr; 22(2):647-8. PubMed ID: 2327008
[No Abstract] [Full Text] [Related]
14. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
Taskinen MR; Groop L
Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
[No Abstract] [Full Text] [Related]
15. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
[No Abstract] [Full Text] [Related]
16. C-peptide profiles in young diabetics.
Nihalani KD; Varthakavi PK; Patel KL; Merchant PC
J Assoc Physicians India; 1993 Jun; 41(6):345-9. PubMed ID: 8005969
[TBL] [Abstract][Full Text] [Related]
17. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
[TBL] [Abstract][Full Text] [Related]
18. A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
Matsuda A; Kamata I; Iwamoto Y; Sakamoto Y; Kuzuya T
Diabetes Res Clin Pract; 1985 Oct; 1(3):161-7. PubMed ID: 3915262
[TBL] [Abstract][Full Text] [Related]
19. The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study.
Service FJ; Rizza RA; Zimmerman BR; Dyck PJ; O'Brien PC; Melton LJ
Diabetes Care; 1997 Feb; 20(2):198-201. PubMed ID: 9118774
[TBL] [Abstract][Full Text] [Related]
20. [C-peptide (CPR)].
Sato Y; Kaku K
Nihon Rinsho; 1995 Mar; 53 Su Pt 2():619-21. PubMed ID: 8753317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
